Contact
Please use this form to send email to PR contact of this press release:
Vast Therapeutics Awarded Another $2 Million Grant to Combat Rare Respiratory Disease
TO:
Nathan Stasko, Chief Executive Officer
Vast Therapeutics, Inc.
+1 919-321-1726